Independent factors associate with hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring intensive care unit admission: Focusing on the eosinophil-to-neutrophil ratio

被引:17
作者
Chen, Pei-Ku [1 ,2 ]
Hsiao, Yi-Han [1 ,3 ]
Pan, Sheng-Wei [1 ,4 ]
Su, Kang-Cheng [1 ,3 ]
Perng, Diahn-Warng [1 ,2 ]
Ko, Hsin-Kuo [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Inst Physiol, Sch Med, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Publ Hlth, Inst Physiol, Sch Med, Taipei, Taiwan
关键词
COPD EXACERBATIONS; OUTCOMES; GLUCOCORTICOIDS; CLASSIFICATION; INFLAMMATION; BIOMARKERS; SEVERITY;
D O I
10.1371/journal.pone.0218932
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Factors associated with hospital mortality are unclear in patients with acute exacerbation of COPD (AECOPD) requiring intensive care unit (ICU) admission. We aimed to characterize these patients and identify factors associated with hospital mortality. Patients and methods We used a retrospective observational case-control design and recruited patients between January 2015 and March 2017. Of 146 patients enrolled, 24 (16.4%) died during their hospital stay, while 122 survived. Results Multivariate logistic regression analyses revealed factors associated with hospital mortality: age (adjusted odds ratio [AOR] 1.12, 95% CI: 1.03-1.23), C-reactive protein (CRP) level >7.5 mg/dL at the emergency room (AOR 4.52, 95% CI: 1.27-16.04), peak eosinophil-to-neutrophil ratio (ENR) x10(2) on days 8-14 of treatment (AOR 0.22, 95% CI: 0.08-0.63), and in-hospital complications (AOR 4.23, 95% CI: 1.12-15.98) (all P<0.05). After receiver operating characteristic curve analyses, cutoff level for peak ENRx10(2) was 0.224. To examine the synergistic effects of CRP level and peak ENR, we divided patients into four groups: (G0, reference group) Peak ENRx10(2) >0.224 on days 8-14 and initial CRP <7.5 mg/dL; (G1) Peak ENRx10(2) >0.224 on days 8-14 and initial CRP >7.5 mg/dL; (G2) Peak ENRx10(2) <0.224 on days 8-14 and initial CRP <7.5 mg/dL; and (G3) Peak ENRx10(2) <0.224 on days 8-14 and initial CRP >7.5 mg/dL. For G2 and G3 patients, the AOR of mortality was significantly different from that of the reference group (G2: AOR 10.00, P = 0.020; G3: AOR 61.79, P<0.001). The relationship between 28-day mortality and the four groups was statistically significant (log-rank test, P<0.001). Conclusion Older age, initial CRP >7.5 mg/dL, peak ENR on days 8-14, and in-hospital complications were associated with hospital mortality in patients with AECOPD requiring ICU admission. Patients with both biomarkers, initial CRP >7.5 mg/dL, and peak ENRx10(2) <0.224 on days 8-14 of treatment, had an increased risk of hospital mortality.
引用
收藏
页数:14
相关论文
共 34 条
[1]   Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units [J].
Abidi, Khalid ;
Khoudri, Ibtissam ;
Belayachi, Jihane ;
Madani, Naoufel ;
Zekraoui, Aicha ;
Zeggwagh, Amine Ali ;
Abouqal, Redouane .
CRITICAL CARE, 2008, 12 (02)
[2]   Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia [J].
Alaithan, Abdulsalam M. ;
Memon, Javed I. ;
Rehmani, Rifat S. ;
Qureshi, Arif A. ;
Salam, Abdul .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 :819-823
[3]   Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease A Randomized Placebo-Controlled Trial [J].
Bafadhel, Mona ;
McKenna, Susan ;
Terry, Sarah ;
Mistry, Vijay ;
Pancholi, Mitesh ;
Venge, Per ;
Lomas, David A. ;
Barer, Michael R. ;
Johnston, Sebastian L. ;
Pavord, Ian D. ;
Brightling, Christopher E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (01) :48-55
[4]   Acute Exacerbations of Chronic Obstructive Pulmonary Disease Identification of Biologic Clusters and Their Biomarkers [J].
Bafadhel, Mona ;
McKenna, Susan ;
Terry, Sarah ;
Mistry, Vijay ;
Reid, Carlene ;
Haldar, Pranabashis ;
McCormick, Margaret ;
Haldar, Koirobi ;
Kebadze, Tatiana ;
Duvoix, Annelyse ;
Lindblad, Kerstin ;
Patel, Hemu ;
Rugman, Paul ;
Dodson, Paul ;
Jenkins, Martin ;
Saunders, Michael ;
Newbold, Paul ;
Green, Ruth H. ;
Venge, Per ;
Lomas, David A. ;
Barer, Michael R. ;
Johnston, Sebastian L. ;
Pavord, Ian D. ;
Brightling, Christopher E. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (06) :662-671
[5]   Inflammatory mechanisms in patients with chronic obstructive pulmonary disease [J].
Barnes, Peter J. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) :16-27
[6]  
Brightling C E, 2013, Ann Am Thorac Soc, V10 Suppl, pS214, DOI 10.1513/AnnalsATS.201302-023AW
[7]   Factors associated with hospital mortality in critically ill patients with exacerbation of COPD [J].
Brown, Hamish ;
Dodic, Stefan ;
Goh, Sheen Sern ;
Green, Cameron ;
Wang, Wei C. ;
Kaul, Sameer ;
Tiruvoipati, Ravindranath .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 :2361-2366
[8]   Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions [J].
Couillard, Simon ;
Larivee, Pierre ;
Courteau, Josiane ;
Vanasse, Alain .
CHEST, 2017, 151 (02) :366-373
[9]   Predicting In-Hospital Treatment Failure (≤7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids [J].
Crisafulli, Ernesto ;
Torres, Antoni ;
Huerta, Arturo ;
Guerrero, Monica ;
Gabarrus, Albert ;
Gimeno, Alexandra ;
Martinez, Raquel ;
Soler, Nestor ;
Fernandez, Laia ;
Wedzicha, Jadwiga A. ;
Menendez, Rosario .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (01) :82-92
[10]   The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [J].
Duman, Dildar ;
Aksoy, Emine ;
Agca, Meltem Coban ;
Kocak, Nagihan Durmus ;
Ozmen, Ipek ;
Akturk, Ulku Aka ;
Gungor, Sinem ;
Tepetam, Fatma Merve ;
Eroglu, Selma Aydogan ;
Oztas, Selahattin ;
Karakurt, Zuhal .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :2469-2478